How did we do?Taking research furtherThanks to our generous donors, we were able to invest £1M in ourpioneering researchers.Funding groundbreaking clinic trialsUsing AI to improve patient outcomesWe awarded £47K towards a large clinical trialinvestigating the use of betablockers to slow theprogression of liver cirrhosis. The largest trial of itskind in the UK, the study will also investigate whybetablockers work for some patients and not others.The team believe participants will experience areduction rate in the progression of their disease andthe trials will also generate a biobank of samples thatcan be used to answer important questions about livercirrhosis in the future.Our grant of £62K will help Professor Timothy Jacksondevelop a machine-learning system to determinewhether a person has elevated pressure inside theirbrain by automatically detecting and interpreting therhythmic pulsations at the back of the eye. The projecthas the potential to diagnose intracranial pressuremuch earlier, improving treatment options andeliminating the need for invasive tests.Urology patient Greg McCarthy (L),pictured with his surgeon,Mr Kawa Omar (R).Improvingoutcomes for patientsOur funding ensures that King’spatients and sta昀昀 have access tothe best equipment and facilities.£12Ktowards a new bladder scanner thatwill be used across three liver wardsto help reduce patient waiting times£13Ktowards vCreate: a secure videomessaging service that helps minimiseseparation anxiety and provide greaterreassurance to neonatal unit parents£21Ktowards two Lifestart trolleys thatenable the mother to be alongsideher baby if resuscitation is neededbefore the umbilical cord is clampedRobot assistedsurgery is payingdividendsLast year, we invested £1Mtowards a state-of-the-art RobotAssisted Surgical (RAS) system to deliver significantbenefits to patients and staff. With improved surgicalprecision and increased patient satisfaction, 236procedures have been carried out since May 2023.Compared to the equivalent colorectal and bariatriclaparoscopic surgeries, on average RAS proceduresrequired 65% less pain relief, length of stay was reducedby over two days, and the conversion rate to opensurgery was lowered by 95%.The whole process was so quick ande昀케cient. As a cancer patient with anewborn baby, ge琀琀ing up and aboutand back to normal family life wasimportant. In fact my recovery was soquick that some of my friends didn’t evenknow that I’d been in for an operation!”– Greg McCarthy, robot assisted surgery patient16S U P P O R T K I N G S .O R G .U K
It seems that your browser's pop-up blocker has prevented us from opening a new window/tab. Please click the button below to open the link manually.
